| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Novel PRKAR1A::MET Fusion Dramatic Response to Crizotinib in a Patient with Unresectable Lung Cancer
|
Yang, Yang
|
|
|
24 |
1 |
p. e50-e54
|
article
|
| 2 |
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era
|
Gonugunta, Amrit S.
|
|
|
24 |
1 |
p. 11-17
|
article
|
| 3 |
Clinical Outcomes and Prognosis of Patients With Interstitial Lung Disease Undergoing Lung Cancer Surgery: A Propensity Score Matching Study
|
Ki, Min Seo
|
|
|
24 |
1 |
p. e27-e38
|
article
|
| 4 |
Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort Multicenter Interventional Study of Osimertinib with or Without Savolitinib in De Novo MET Aberrant, EGFR-Mutant Patients with Advanced Non-Small-Cell Lung Cancer: The FLOWERS Trial
|
Li, Anna
|
|
|
24 |
1 |
p. 82-88
|
article
|
| 5 |
Editorial Board
|
|
|
|
24 |
1 |
p. A1
|
article
|
| 6 |
Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy
|
Fu, Jing
|
|
|
24 |
1 |
p. 29-39
|
article
|
| 7 |
Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC
|
Ganesh, Ashwin
|
|
|
24 |
1 |
p. 60-71
|
article
|
| 8 |
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study
|
Mordant MD, PhD, Pierre
|
|
|
24 |
1 |
p. 1-10
|
article
|
| 9 |
Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm
|
Tran, Jessica H.
|
|
|
24 |
1 |
p. e9-e18
|
article
|
| 10 |
Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical Resection
|
Yu, Lian
|
|
|
24 |
1 |
p. e1-e8
|
article
|
| 11 |
Real-world ALK Testing Trends in Patients With Advanced Non–Small-Cell Lung Cancer in the United States
|
Lin, Huamao M.
|
|
|
24 |
1 |
p. e39-e49
|
article
|
| 12 |
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer
|
Schmid, Sabine
|
|
|
24 |
1 |
p. 40-50
|
article
|
| 13 |
Regression of Malignant Pleural Mesothelioma in Absence of Chemotherapy or Surgery: A Case Series
|
Nief, Corrine A.
|
|
|
24 |
1 |
p. 76-81
|
article
|
| 14 |
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers
|
Spitaleri, G.
|
|
|
24 |
1 |
p. e19-e26
|
article
|
| 15 |
Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report
|
Gazeu, Alexia
|
|
|
24 |
1 |
p. 72-75
|
article
|
| 16 |
Table of Contents
|
|
|
|
24 |
1 |
p. A2-A4
|
article
|
| 17 |
The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5
|
Sui, Qihai
|
|
|
24 |
1 |
p. 51-59
|
article
|
| 18 |
The Value of Radiotherapy in Patients With Resectable Stage IIIA Non–Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis
|
Liu, Bohao
|
|
|
24 |
1 |
p. 18-28
|
article
|
Journal description